Table 1.
Table Cohort Studies of CT Exposure and Cancer Incidence
| Country | Exposed Cohort Size | Exposed Age Range | Start Accrual | Estimated Report |
|---|---|---|---|---|
| Belgium | 30,000 | 0–15 | 2002 | 2016 |
| Denmark | 30,000 | 0–18 | 2000 | 2016 |
| France | 90,000 | 0–5 | 2000 | 2016 |
| Germany | 140,000 | 0–15 | 1985 | 2016 |
| Netherlands | 40,000 | 0–18 | 1998 | 2016 |
| Norway | 20,000 | 0–20 | 2005 | 2016 |
| Spain | 200,000 | 0–20 | 2005 | 2016 |
| Sweden | 95,000 | 0–18 | 1984 | 2016 |
| UK | 400,000 | 0–21 | 1985 | 2012 |
| EPI-CT (Pooled European) | 1,045,000 | 0–21 | 1984–2002 | 2016 |
| Australia | 660,000 | 0–19 | 1985 | 2012–3 |
| Canada (Ontario) | 370,000 | 0–17 | 1985 | 2013 |
| Canada (Ontario) | 4,105,000 | 18+ | 1991 | 2013 |
| Israel | 42,000 | 0–22 | 1985 | 2013 |
| Israel | 18,000 | 0–22 | 1999 | 2013 |
European studies adapted from http://epi-ct.iarc.fr/index.php
Additional data kindly provided by Drs. Gabriel Chodick, Ausrele Kesminiene, Vicki Kirsh, John Mathews, and Isabelle Thierry-Chef.